Early Development

CatSci is committed to finding the most sustainable routes for your project, which starts with route scouting and selection. Discover how our expertise can help you increase efficiency and reduce waste of your reactions and processes. Check out our case study on effective route scouting here.

We work efficiently and effectively with you to scale up your processes from milligrams to kilos. Our early scale-up solutions ensure the safety, proficiency and economic sustainability of your processes from the start.

CatSci can safely manage the full complexity of your projects. We have the capabilities to help de-risk your pharmaceutical pipeline of small molecule assets, by safely and securely delivering all your project demands.

Our project leads work with you to understand your specific goals to ensure tailored analytical methodology. We have a 3:1 chemist-to-analyst ratio and 100 years of combined experience of analytical problem solving. ​Check out our case study on Method development for high-throughput sample analysis here.

We are dedicated to accelerating medicines development by breaking down the barriers between drug substance and drug product. Our Feedforward approach to API process development enables you to identify and mitigate your project risks before they happen, ultimately ensuring delivery of your asset at every stage quickly and efficiently. Check out our blog on the physical chemistry of salt screening.

We possess a variety of enabling technologies in a multitude of areas, including catalysis, which allows us to take advantage of the right tools to bring you access to the best chemistry. By utilising state-of-the-art technology, we help you to create small molecule therapeutics in a safer, greener and more cost-effective manner. Take a look at our recent OPR&D paper on developing an iron-catalysed opioid demethylation.